Increased adoption of clinical whole-genome sequencing is advancing diagnostics for rare diseases, which affect 15 million American children SAN DIEGO, Feb. 27, 2026 /PRNewswire/ — Illumina, Inc. (NASDAQ: ILMN) today announced that Illumina Laboratory Services, Illumina’s CLIA-certified…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
